GO
Loading...

Human Genome Rejects GlaxoSmithKline's Bid

Thursday, 19 Apr 2012 | 12:41 PM ET

Human Genome Sciences rejected the $2.6 billion unsolicited takeover bid from GlaxoSmithKline, reports CNBC's Herb Greenberg.